Atrial Fibrillation

/Tag:Atrial Fibrillation

A RARE CAUSE OF A HEART ATTACK: A CASE REPORT OF ATRIAL FIBRILLATION CAUSING MYOCARDIAL INFARCTION

Case Presentation: A 58-year-old obese African American man, non-smoker with past medical history of hypertension and atrial fibrillation (on Coumadin) presents to our emergency room with chest pain. Patient describes the pain as acute onset, [...]

By | 2018-03-19T13:07:37+00:00 March 19th, 2018|Adult, Clinical Vignettes, Hospital Medicine 2018|Comments Off on A RARE CAUSE OF A HEART ATTACK: A CASE REPORT OF ATRIAL FIBRILLATION CAUSING MYOCARDIAL INFARCTION

A RARE, BUT DEVASTATING, COMPLICATION AFTER RADIOFREQUENCY ABLATION

Case Presentation: A 62-year-old male with a history of paroxysmal atrial fibrillation presented with hypotension and 2 week history of chest pain after an ablation with pulmonary vein isolation. Transthoracic echocardiography demonstrated a pericardial effusion. [...]

By | 2019-03-18T17:15:16+00:00 March 11th, 2019|Adult, Clinical Vignettes, Finalist Posters - Clinical Vignettes, Adult, Hospital Medicine 2019|Comments Off on A RARE, BUT DEVASTATING, COMPLICATION AFTER RADIOFREQUENCY ABLATION

AMIODARONE: FRIEND OR FOE

Case Presentation: A 73 year old woman with known ischemic cardiomyopathy with reduced ejection fraction and atrial fibrillation on Amiodarone presented with decompensated heart failure. Work up revealed Thyroid Stimulating Hormone (TSH) 0.0008 UIU/ML, Free [...]

By | 2019-03-11T14:41:49+00:00 March 11th, 2019|Adult, Clinical Vignettes, Hospital Medicine 2019|Comments Off on AMIODARONE: FRIEND OR FOE

Analysis of Severe Gastrointestinal Bleed in Patients on Anticoagulation for Atrial Fibrillation and Abnormal Endoscopic Evaluation

Background: Widespread use of new oral anticoagulants (NOAG) for Atrial Fibrillation (A-Fib) has increased the annual incidence of gastrointestinal bleed (GIB) in recent years. These NOAG agents in our study include Rivaroxaban, Apixaban and Dabigatran. [...]

By | 2016-02-01T08:00:34+00:00 February 1st, 2016|Patient Safety, Research Abstracts|Comments Off on Analysis of Severe Gastrointestinal Bleed in Patients on Anticoagulation for Atrial Fibrillation and Abnormal Endoscopic Evaluation

ANGIOTENSIN CONVERTING ENZYME INHIBITOR REDUCES THE INCIDENCE OF ATRIAL FIBRILLATION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION PATIENTS: A RETROSPECTIVE COHORT STUDY FROM THE TOPCAT TRIAL

Background: Heart failure (HF) and atrial fibrillation (AF) share several risk factors including coronary artery disease, hypertension, smoking, obesity, diabetes, and renal disease, as well as common pathophysiologic pathway involving activation of the renin–angiotensin–aldosterone system, [...]

By | 2019-03-11T14:19:49+00:00 March 11th, 2019|Hospital Medicine 2019, Outcomes Research, Research|Comments Off on ANGIOTENSIN CONVERTING ENZYME INHIBITOR REDUCES THE INCIDENCE OF ATRIAL FIBRILLATION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION PATIENTS: A RETROSPECTIVE COHORT STUDY FROM THE TOPCAT TRIAL

ASSOCIATION OF ATRIAL FIBRILLATION WITH IN-HOSPITAL OUTCOMES AND 30-DAY READMISSION RATE FOLLOWING HOSPITALIZATION FOR SEPSIS IN THE ELDERLY PATIENTS

Background: The annual incidence of sepsis is about 1.7 million in the United States and about 270,000 Americans die as a result of sepsis each year. Atrial fibrillation is the most common arrhythmia seen in [...]

By | 2019-03-11T14:26:49+00:00 March 11th, 2019|Hospital Medicine 2019, Research, Value in Hospital Medicine|Comments Off on ASSOCIATION OF ATRIAL FIBRILLATION WITH IN-HOSPITAL OUTCOMES AND 30-DAY READMISSION RATE FOLLOWING HOSPITALIZATION FOR SEPSIS IN THE ELDERLY PATIENTS

COMPLICATIONS OF TREATING ATRIAL FIBRILLATION BY CATHETER ABLATION

Case Presentation: Introduction: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. In the past decade, catheter ablation of AF has evolved from an investigational procedure to a frequent therapeutic one. Phrenic nerve injury [...]

By | 2018-03-19T13:23:27+00:00 March 19th, 2018|Adult, Clinical Vignettes, Hospital Medicine 2018|Comments Off on COMPLICATIONS OF TREATING ATRIAL FIBRILLATION BY CATHETER ABLATION

COR TRIATRIATUM AND ATRIAL FIBRILLATION

Case Presentation: A 63 year-old woman with history of untreated hyperthyroidism presents to the emergency room with an outpatient abnormal ECG showing atrial fibrillation with rapid ventricular response. At the time, the patient was complaining [...]

By | 2017-04-20T16:02:44+00:00 April 20th, 2017|Adult, Clinical Vignette Abstracts|Comments Off on COR TRIATRIATUM AND ATRIAL FIBRILLATION

DRESSLER SYNDROME: A EMERGING COMPLICATION OF ABLATIVE THERAPY FOR ATRIAL FIBRILLATION.

Case Presentation: A 53 year old female originally underwent an ablation for atrial fibrillation with post procedure course pericardial effusion requiring drain placement for 3 days. Patient recovered from original effusion and was sent home [...]

By | 2018-03-19T13:02:20+00:00 March 19th, 2018|Adult, Clinical Vignettes, Hospital Medicine 2018|Comments Off on DRESSLER SYNDROME: A EMERGING COMPLICATION OF ABLATIVE THERAPY FOR ATRIAL FIBRILLATION.

EFFECT OF ASPIRIN USE ON THE EFFICACY AND SAFETY OF THE DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS

Background: Over 6 million people in the US have a diagnosis of atrial fibrillation. Given the increased risk for stroke and systemic embolism, many patients are treated with direct oral anticoagulants (DOACs) to reduce their [...]

By | 2018-03-19T13:10:27+00:00 March 19th, 2018|Hospital Medicine 2018, Outcomes Research, Research|Comments Off on EFFECT OF ASPIRIN USE ON THE EFFICACY AND SAFETY OF THE DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS

EFFICACY AND SAFETY OF APIXABAN IN COMPARISON WITH WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS.

Background: Atrial fibrillation leads to increased risk of systemic embolism (SE) and stroke. To decrease the occurrence of stroke/SE, anticoagulation is routinely prescribed. Recently, non-vitamin K anticoagulants like apixaban and rivaroxaban have become more popular [...]

By | 2019-03-11T14:20:05+00:00 March 11th, 2019|Hospital Medicine 2019, Outcomes Research, Research|Comments Off on EFFICACY AND SAFETY OF APIXABAN IN COMPARISON WITH WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS.

EFFICACY AND SAFETY OF PERI-OPERATIVE BRIDGING ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING ELECTIVE SURGICAL PROCEDURE: A SYSTEMATIC REVIEW AND META-ANALYSIS.

Background: Atrial fibrillation (AF) is a very common condition which usually requires anticoagulation (AC). There are very clear indications of when to initiate AC but recommendations regarding bridging during elective surgery are not very clear. [...]

By | 2019-03-11T14:20:07+00:00 March 11th, 2019|Hospital Medicine 2019, Outcomes Research, Research|Comments Off on EFFICACY AND SAFETY OF PERI-OPERATIVE BRIDGING ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING ELECTIVE SURGICAL PROCEDURE: A SYSTEMATIC REVIEW AND META-ANALYSIS.

Esophago-Atrial Fistula After Atrial Fibrillation Catheter Ablation: Not Just a Chest Pain!

Case Presentation: A 65-year-old male presented with sharp severe chest pain, worsened with respiratory movements. One day prior to admission, patient had catheter ablation due to persistent atrial fibrillation. He had no other medical history. [...]

By | 2016-02-01T08:00:34+00:00 February 1st, 2016|Adult, Clinical Vignettes Abstracts|Comments Off on Esophago-Atrial Fistula After Atrial Fibrillation Catheter Ablation: Not Just a Chest Pain!

HOW WELL DO WE DO? AN IN-DEPTH ANALYSIS OF ATRIAL FIBRILLATION CARE BASED UPON THE 2016 ACC/AHA CLINICAL PERFORMANCE AND QUALITY MEASURES FOR ADULTS WITH ATRIAL FIBRILLATION

Background: Atrial fibrillation (AFIB) is the most common recognized arrhythmia in the United States. Currently affecting more than 6 million people, this number is expected to double by 2050. Along with increased costs ($26 billion/year), [...]

By | 2019-03-11T14:22:13+00:00 March 11th, 2019|Hospital Medicine 2019, Quality Improvement, Research|Comments Off on HOW WELL DO WE DO? AN IN-DEPTH ANALYSIS OF ATRIAL FIBRILLATION CARE BASED UPON THE 2016 ACC/AHA CLINICAL PERFORMANCE AND QUALITY MEASURES FOR ADULTS WITH ATRIAL FIBRILLATION